STERIS (STE) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

STERIS Revenue Highlights


Latest Revenue (Y)

$5.14B

Latest Revenue (Q)

$1.28B

Main Segment (Y)

Product

Main Geography (Y)

UNITED STATES

STERIS Revenue by Period


STERIS Revenue by Year

DateRevenueChange
2024-03-31$5.14B3.65%
2023-03-31$4.96B8.13%
2022-03-31$4.59B47.55%
2021-03-31$3.11B2.53%
2020-03-31$3.03B8.94%
2019-03-31$2.78B6.19%
2018-03-31$2.62B0.28%
2017-03-31$2.61B16.71%
2016-03-31$2.24B21.00%
2015-03-31$1.85B14.06%
2014-03-31$1.62B8.01%
2013-03-31$1.50B7.93%
2012-03-31$1.39B15.24%
2011-03-31$1.21B-4.00%
2010-03-31$1.26B-3.14%
2009-03-31$1.30B2.64%
2008-03-31$1.27B5.65%
2007-03-31$1.20B3.20%
2006-03-31$1.16B3.62%
2005-03-31$1.12B3.01%
2004-03-31$1.09B11.82%
2003-03-31$972.09M12.16%
2002-03-31$866.70M8.33%
2001-03-31$800.09M5.19%
2000-03-31$760.63M-4.64%
1999-03-31$797.60M10.83%
1998-03-31$719.66M22.41%
1997-03-31$587.90M544.63%
1996-03-31$91.20M41.84%
1995-03-31$64.30M40.39%
1994-03-31$45.80M-

STERIS generated $5.14B in revenue during NA 2024, up 3.65% compared to the previous quarter, and up 184.70% compared to the same period a year ago.

STERIS Revenue by Quarter

DateRevenueChange
2024-06-30$1.28B-9.86%
2024-03-31$1.42B1.70%
2023-12-31$1.40B3.97%
2023-09-30$1.34B4.50%
2023-06-30$1.28B-7.24%
2023-03-31$1.38B13.89%
2022-12-31$1.22B1.29%
2022-09-30$1.20B3.81%
2022-06-30$1.16B-4.48%
2022-03-31$1.21B0.14%
2021-12-31$1.21B1.00%
2021-09-30$1.20B23.60%
2021-06-30$968.42M10.86%
2021-03-31$873.53M7.99%
2020-12-31$808.92M6.98%
2020-09-30$756.13M13.04%
2020-06-30$668.93M-18.72%
2020-03-31$822.99M6.29%
2019-12-31$774.26M5.08%
2019-09-30$736.84M5.75%
2019-06-30$696.80M-9.30%
2019-03-31$768.21M10.34%
2018-12-31$696.24M2.54%
2018-09-30$678.96M6.29%
2018-06-30$638.76M-10.78%
2018-03-31$715.97M8.17%
2017-12-31$661.90M4.37%
2017-09-30$634.16M4.31%
2017-06-30$607.96M-10.75%
2017-03-31$681.19M5.32%
2016-12-31$646.77M0.06%
2016-09-30$646.41M1.26%
2016-06-30$638.38M-7.52%
2016-03-31$690.28M56.92%
2015-12-31$439.90M-10.21%
2015-09-30$489.90M-20.82%
2015-06-30$618.69M23.33%
2015-03-31$501.65M21.57%
2014-12-31$412.64M-10.82%
2014-09-30$462.73M-2.22%
2014-06-30$473.24M1.71%
2014-03-31$465.29M26.56%
2013-12-31$367.65M-4.20%
2013-09-30$383.76M-5.37%
2013-06-30$405.55M-5.29%
2013-03-31$428.22M27.08%
2012-12-31$336.96M-5.43%
2012-09-30$356.32M-6.33%
2012-06-30$380.40M-2.52%
2012-03-31$390.25M22.47%
2011-12-31$318.64M-7.02%
2011-09-30$342.71M-3.52%
2011-06-30$355.21M-5.97%
2011-03-31$377.76M99.89%
2010-12-31$188.98M-39.51%
2010-09-30$312.43M-4.83%
2010-06-30$328.28M-1.16%
2010-03-31$332.13M17.14%
2009-12-31$283.54M-9.77%
2009-09-30$314.23M-4.15%
2009-06-30$327.83M-4.80%
2009-03-31$344.37M10.53%
2008-12-31$311.56M-3.58%
2008-09-30$323.13M1.15%
2008-06-30$319.47M-14.85%
2008-03-31$375.17M-

STERIS generated $1.28B in revenue during Q1 2025, up -9.86% compared to the previous quarter, and up 92.39% compared to the same period a year ago.

STERIS Revenue Breakdown


STERIS Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceMar 24Mar 22Mar 21Mar 20Mar 19
Service$2.37B$2.03B$1.66B$1.63B$1.49B
Product$2.76B$2.56B$1.44B$1.40B$1.30B

STERIS's latest annual revenue breakdown by segment (product or service), as of Mar 24: Product (53.79%), and Service (46.21%).

Quarterly Revenue by Product

Product/ServiceJun 24Mar 24Dec 23Sep 23Jun 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
Product$656.29M$483.00M$804.76M$762.34M$713.86M$679.04M$666.39M$637.08M$684.51M$697.26M$685.24M$489.28M$427.61M$375.31M$339.50M$301.11M$393.59M$363.80M$337.67M$307.74M
Service$623.21M$633.15M$590.89M$580.02M$570.68M$536.95M$534.12M$519.41M$526.18M$511.71M$511.75M$479.14M$445.92M$433.61M$416.63M$367.82M$429.40M$410.47M$399.17M$389.07M

STERIS's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Product (51.29%), and Service (48.71%).

STERIS Revenue Breakdown by Country

Annual Revenue by Country

CountryMar 24Mar 22Mar 21Mar 20Mar 19
UNITED STATES$3.75B$3.23B$2.23B$2.21B$1.98B
Other foreign locations$1.30B$1.27B$808.58M$755.35M$748.57M
IRELAND$82.69M$82.01M$71.91M$63.82M-
Service-$2.03B---
Product-$2.56B---

STERIS's latest annual revenue breakdown by geography, as of Mar 24: UNITED STATES (73.00%), Other foreign locations (25.39%), and IRELAND (1.61%).

Quarterly Revenue by Country

CountryJun 24Mar 24Dec 23Sep 23Jun 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
UNITED STATES$946.89M$802.56M$1.03B$992.88M$930.54M$883.39M$871.98M$834.10M$845.83M$851.29M$852.50M$679.25M$613.48M$572.40M$549.45M$491.71M$599.97M$562.50M$538.10M$511.15M
IRELAND$22.19M$22.52M$19.65M$20.44M$20.09M$17.96M$17.00M$18.18M$19.93M$20.09M$20.05M$21.95M$20.13M$20.32M$17.09M$14.37M$17.42M$16.13M$15.17M$15.11M
Other foreign locations$310.42M$291.07M$350.54M$329.04M$333.92M$314.64M$311.54M$304.21M$344.93M$337.59M$324.44M$267.23M$239.92M$216.21M$189.59M$162.85M$205.61M$195.63M$183.57M$170.54M

STERIS's latest quarterly revenue breakdown by geography, as of Jun 24: UNITED STATES (74.00%), Other foreign locations (24.26%), and IRELAND (1.73%).

STERIS Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
SYKStryker$20.50B$5.49B
SNNSmith & Nephew$5.55B$2.79B
STESTERIS$5.14B$1.28B
BRKRBruker$2.96B$800.70M
MASIMasimo$2.05B$492.80M
PODDInsulet$1.70B$488.50M
ITGRInteger$1.60B$746.27M
CNMDCONMED$1.24B$316.70M
LIVNLivaNova$1.15B$318.11M
PENPenumbra$1.06B$301.04M
IRTCiRhythm$492.68M$147.54M
ZIMVZimVie$457.43M$103.22M
GKOSGlaukos$314.71M$95.69M
ANIKAnika Therapeutics$166.66M$41.92M
OFIXOrthofix Medical$100.00K$198.62M

STE Revenue FAQ


STERIS's yearly revenue for 2024 was $5.14B, representing an increase of 3.65% compared to 2023. The company's yearly revenue for 2023 was $4.96B, representing an increase of 8.13% compared to 2022. STE's yearly revenue for 2022 was $4.59B, representing an increase of 47.55% compared to 2021.

STERIS's quarterly revenue for Q1 2025 was $1.28B, a -9.86% decrease from the previous quarter (Q4 2024), and a -0.39% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $1.42B, a 1.70% increase from the previous quarter (Q3 2024), and a 2.49% increase year-over-year (Q4 2023). STE's quarterly revenue for Q3 2024 was $1.4B, a 3.97% increase from the previous quarter (Q2 2024), and a 14.77% increase year-over-year (Q3 2023).

STERIS's revenue growth rate for the last 3 years (2022-2024) was 12.07%, and for the last 5 years (2020-2024) was 69.54%.

STERIS's revenue streams in r 24 are Service, and Product. Service generated $2.37B in revenue, accounting 46.21% of the company's total revenue, up 17.05% year-over-year. Product generated $2.76B in revenue, accounting 53.79% of the company's total revenue, up 8.12% year-over-year.

For the fiscal year ending Mar 24, the largest source of revenue of STERIS was Product. This segment made a revenue of $2.76B, representing 53.79% of the company's total revenue.